Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | +8613726739909 |
| E-mail: | pengguizi@cti-cert.com |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| N-Nitroso desmethyl Bedaquiline | C31H28BrN3O3 | Details |
| (R,S)-N-NITROSOANABASINE | C10H13N3O | 37620-20-5 | Details |
| N-Nitroso desmethyl Amitriptyline | C19H20N2O | 55855-42-0 | Details |
| N-Nitroso Bendroflumethiazide | Details |
| N-Nitroso Benzonatate | Details |
| N-Nitroso Belumosudil | Details |
| N-Nitroso Avacopan | Details |
| N-Nitroso Acebutolol | C18H27N3O5 | Details |
| N-Nitroso desmethyl Almotriptan | Details |
| N-Nitroso Albuterol | C13H20N2O4 | 2919946-71-5 | Details |
| Benzenebutanoic acid, γ-cyano-3,4-dimethoxy-γ-(1-methylethyl)-, (γS)-, compd. with (αR)-α-methylbenzenemethanamine (1:1) | C16H21NO4.C8H11N | 194854-18-7 | Details |
| N-Nitroso Amoxapine | C17H15ClN4O2 | Details |
| N-Nitroso Argatroban | C23H35N7O6S | Details |
| 2-bromo-3-methylpropiophenone | C10H11BrO | 1451-83-8 | Details |
| 2-(Cyclohept-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C13H23BO2 | 287944-13-2 | Details |
| tert-Butyl (2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)carbamate | C9H15F3N2O3 | 1231755-15-9 | Details |
| Ethyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | C9H12N2O3 | 518990-21-1 | Details |
| 1-methyl-1H-imidazole-5-boronic acid pinacol este | C10H17BN2O2 | 942070-72-6 | Details |
| Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, anhydride with 2-methylpropyl hydrogen carbonate | C12H21NO6 | 66866-43-1 | Details |
| 2-Amino-1-morpholinoethanone | C6H12N2O2 | 56414-96-1 | Details |
| 2,6-difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | C12H16BF2NO2 | 939968-08-8 | Details |
| Ruxolitinib | C17H18N6 | 941678-49-5 | Details |
| Ibubinib impurity 07 | C25H26N6O2 | 1839099-22-7 | Details |
| Crizotinib Impurity 03 | C21H23ClFN5O | 1801651-84-2 | Details |
| Trametinib Impurity 13 | C25H21FIN3O6S | 871700-32-2 | Details |
| Crizotinib | C21H22Cl2FN5O | 877399-52-5 | Details |
| Erlotinib hydrochloride | C22H24ClN3O4 | 183319-69-9 | Details |
| Sunitinib Malate | C26H33FN4O7 | 341031-54-7 | Details |
| GSK1120212 (DMSO solvate) | C28H29FIN5O5S | 1187431-43-1 | Details |
| Sorafenib tosylate | C21H16ClF3N4O3.C7H8O3S | 475207-59-1 | Details |
| lenvatinib Mesylate | C22H23ClN4O7S | 857890-39-2 | Details |
| Ibrutinib Impurity | C50H48N12O4 | 2417548-76-4 | Details |
| Pomalidomide | C13H11N3O4 | 19171-19-8 | Details |
| Nilotinib Hydrochloride | C28H23ClF3N7O | 923288-95-3 | Details |
| LenalidoMide | C13H13N3O3 | 191732-72-6 | Details |
| Imatinib mesylate | C30H35N7O4S | 220127-57-1 | Details |
| Trametinib Impurity 15 | C15H16N2O3S | 329941-39-1 | Details |
| Trametinib Impurity 03 | C16H16FIN4O2 | 871700-30-0 | Details |
| Trametinib Impurity 02 | C13H11FIN3O2 | 871700-28-6 | Details |
| Trametinib Impurity 21 | C24H21FIN5O3 | 871701-87-0 | Details |
| Trametinib Impurity 20 | C26H23FIN5O4 | 871701-23-4 | Details |
| Trametinib Impurity 19 | C17H17FIN3O3 | 3018911-27-5 | Details |
| Trametinib Impurity 11 | C26H23FIN5O4 | 871700-25-3 | Details |
| Trametinib Impurity 17 | C26H24FN5O4 | 871700-65-1 | Details |
| Ibubinib impurity 06 | C24H24N6O2 | 1288338-95-3 | Details |
| Ibubinib impurity 04 | C50H48N12O4 | 2031255-23-7 | Details |
| Ibubinib impurity 02 | C25H24N6O2 | 936563-96-1 | Details |
| Ibubinib impurity 03 | C47H46N12O3 | 1987905-93-0 | Details |
| Ibubinib impurity 08 | C26H28N6O3 | 2031255-26-0 | Details |
| Ibubinib impurity 12 | C25H24N6O2 | 936563-92-7 | Details |
| Crizotinib Impurity05 | C23H24Cl2FN5O2 | 2925080-43-7 | Details |
| Crizotinib Impurity 04 | C16H13Cl2FN4O | 3026867-46-6 | Details |
| Crizotinib Impurity10 | C21H22Cl2FN5O | 1374356-45-2 | Details |
| Crizotinib Impurity09 | C23H26Cl2FN5O | 1428476-77-0 | Details |
| Dasatinib Impurity 1 | Details |
| Palbociclib Impurity02 | C22H26BrN7O | 851067-56-6 | Details |
| Palbociclib Impurity03 | C25H29N7O3 | 2174002-16-3 | Details |
| Palbociclib Impurity04 | C15H18N4O2 | 571189-64-5 | Details |
| Palbociclib Impurity1 | C36H28O3P2 | 808142-23-6 | Details |
| Palbociclib Impurity11 | C16H24N4O3 | 1311611-88-7 | Details |
| Dasatinib Impurity01 | C20H22ClN7OS | 910297-51-7 | Details |
| Dasatinib Impurity07 | C15H20N6O3S | 1245157-42-9 | Details |
| Ruxolitinib Impurity4 | C18H20N6O | 41685-37-6 | Details |
| Palbociclib Impurity | C22H28ClN7O | Details |
| Ruxolitinib Impurity2 | Details |
| Palbociclib Impurit 01 | C22H27N7O | 571190-22-2 | Details |
| Palbociclib Impurity08 | C14H22N4O2 | 1023594-49-1 | Details |
| Palbociclib Impurity07 | C13H13Br2N3O | 1415560-29-0 | Details |
| Palbociclib Impurity12 | C13H14BrN3O2 | 1922954-32-2 | Details |
| Palbociclib Impurity15 | C24H29N7O2 | 2204368-66-9 | Details |
| Ruxolitinib Impurity 30 | C16H18N6O | 2606144-45-8 | Details |
| Dasatinib Impurity10 | C16H13Cl2N5OS | 302964-08-5 | Details |
| Dasatinib Impurity09 | C11H10ClN3OS | 302964-24-5 | Details |
| Ruxolitinib Impurity12 | 3016399-18-8 | Details |
| Ruxolitinib Impurity 05 | C17H19N5O2 | 2102675-40-9 | Details |
| Dasatinib Impurity03 | C36H34Cl2N12O2S2 | 910297-61-9 | Details |
| Dasatinib Impurity02 | C22H26ClN7O3S | 910297-52-8 | Details |
| Dasatinib Impurity04 | C18H24ClN5O | 2099694-53-6 | Details |
| Dasatinib Impurity12 | C5H4Cl2N2 | 1780-26-3 | Details |
| 1-(2-Hydroxyethyl)piperazine | C6H14N2O | 103-76-4 | Details |
| Palbociclib Impurity05 | C27H35N7O3 | 571189-65-6 | Details |
| Palbociclib Impurity09 | C14H18N6 | 2144748-14-9 | Details |
| Ruxolitinib Impurity 01 | C9H7N5 | 952518-97-7 | Details |
| Palbociclib Impurity14 | C29H37N7O3 | 1941177-45-2 | Details |
| Ruxolitinib Impurity 02 | C16H18N6O2 | 2606144-44-7 | Details |
| Dasatinib Impurity08 | C22H27N7O2S | 1184919-23-0 | Details |
| Dasatinib Impurity11 | C12H14ClNO2 | 863127-76-8 | Details |
| Ruxolitinib Impurity 04 | C17H20N6O | 1911644-32-0 | Details |
| Ruxolitinib Impurity 06 | C25H29N7 | 3027185-21-0 | Details |
| Ruxolitinib Impurity 08 | C17H18N6.H3O4P | 2703484-89-1 | Details |
| Ruxolitinib Impurity11 | 2231734-31-7 | Details |
| Ruxolitinib Impurity10 | C25H18ClN3 | 1792190-52-3 | Details |
| Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
| Atrasentan Impurity 01 | C29H38N2O6 | Details |
| Atrasentan Impurity 03 | Details |
| Atrasentan Impurity 04 | Details |
| Atrasentan Impurity 05 | Details |
| Atrasentan Impurity 07 | Details |
| Atrasentan Impurity 08 | Details |
| N-Nitroso tadalafil | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 | ||||